{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T11:17:37Z","timestamp":1790939857698,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urology"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.urology.2003.09.039","type":"journal-article","created":{"date-parts":[[2004,3,12]],"date-time":"2004-03-12T10:20:40Z","timestamp":1079086840000},"page":"596-601","source":"Crossref","is-referenced-by-count":16,"title":["Antitumor effects of recombinant BCG and interleukin-12 DNA vaccines on xenografted murine bladder cancer"],"prefix":"10.1016","volume":"63","author":[{"given":"Dah-Shyong","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Feng","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dar-Shih","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun-Yran","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2003.09.039_BIB1","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0022-5347(17)58737-6","article-title":"Intracavitary bacillus Calmette-Gu\u00e9rin in the treatment of superficial bladder tumors","volume":"116","author":"Morales","year":"1976","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2003.09.039_BIB2","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0022-5347(01)67606-7","article-title":"A randomized study of intravesical mitomycin C, bacillus Calmette-Gu\u00e9rin Tice and bacillus Calmette-Gu\u00e9rin RIVM treatment in pTa-pT1 papillary carcinoma and carcinoma in situ of the bladder","volume":"153","author":"Vegt","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2003.09.039_BIB3","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s101470200042","article-title":"Complications of bacillus Calmette-Gu\u00e9rin therapy in superficial urothelial cancer","volume":"7","author":"Suzuki","year":"2002","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.urology.2003.09.039_BIB4","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/S0140-6736(98)07422-4","article-title":"BCG immunotherapy of bladder cancer","volume":"353","author":"Alexandroff","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.urology.2003.09.039_BIB5","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/1097-0215(20000915)87:6<844::AID-IJC14>3.0.CO;2-5","article-title":"What are the immunologically active components of bacille Calmette-Gu\u00e9rin in therapy of superficial bladder cancer?","volume":"87","author":"Zlotta","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urology.2003.09.039_BIB6","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1128\/IAI.71.4.1672-1679.2003","article-title":"A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis","volume":"71","author":"Horwitz","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.urology.2003.09.039_BIB7","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/sj.cgt.7700330","article-title":"Induction of effective antitumor immune responses in a mouse bladder tumor model by using DNA of an \u03b1 antigen from mycobacteria","volume":"8","author":"Kuromatsu","year":"2001","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.urology.2003.09.039_BIB8","first-page":"37","article-title":"Therapy of bladder cancer with BCG","volume":"2","author":"Brandau","year":"2001","journal-title":"Mod Asp Immunobiol"},{"key":"10.1016\/j.urology.2003.09.039_BIB9","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.4049\/jimmunol.164.9.4635","article-title":"Increased DNA vaccine delivery and immunogenicity by electroporation in vivo","volume":"164","author":"Widera","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.urology.2003.09.039_BIB10","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1128\/IAI.62.6.2508-2514.1994","article-title":"Recombinant Mycobacterium bovis BCG secreting functional interleukine-2 enhances gamma interferon production by splenocytes","volume":"62","author":"O'Donnell","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.urology.2003.09.039_BIB11","first-page":"1005","article-title":"Electroporation-mediated interleukin-12 gene therapy for hepatocellular carcinoma in the mice model","volume":"61","author":"Yamashita","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.urology.2003.09.039_BIB12","first-page":"3281","article-title":"Effective tumor therapy with plasmid-encoded cytokines combined with in vivo electroporation","volume":"61","author":"Lohr","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.urology.2003.09.039_BIB13","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0022-5347(05)67417-4","article-title":"Murine IL-2 secreting recombinant bacillus Calmette-Gu\u00e9rin augments macrophage-mediated cytotoxicity against murine bladder cancer MBT-2","volume":"164","author":"Yamada","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2003.09.039_BIB14","first-page":"793","article-title":"IL-2-secreting recombinant bacillus Calmette Gu\u00e9rin can overcome a type 2 immune response and corticosteroid-induced immunosuppression to elicit a type 1 immune response","volume":"14","author":"Young","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.urology.2003.09.039_BIB15","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0022-5347(17)46976-X","article-title":"Intravesical bacillus Calmette-Gu\u00e9rin therapy for superficial bladder cancer","volume":"134","author":"Kelley","year":"1985","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2003.09.039_BIB16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0022-5347(17)43909-7","article-title":"Requirement of a thymus dependent immune response for BCG-mediated antitumor activity","volume":"137","author":"Ratliff","year":"1987","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2003.09.039_BIB17","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/S0022-5347(05)65642-X","article-title":"Mycobacterial cell wall extract for treatment of carcinoma in situ of the bladder","volume":"166","author":"Morales","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2003.09.039_BIB18","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1517\/14656566.3.6.671","article-title":"Pharmacotherapy of bladder cancer\u2014practice and prospects","volume":"3","author":"Nawrocki","year":"2002","journal-title":"Exp Opin Pharmacother"},{"key":"10.1016\/j.urology.2003.09.039_BIB19","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nm859","article-title":"Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis","volume":"9","author":"Pym","year":"2003","journal-title":"Nat Med"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429503010276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429503010276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T16:23:42Z","timestamp":1585671822000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429503010276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0090429503010276"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2003.09.039","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}